The present study describes a simple stability-indicating reversed-phase HPLC assay
for pentoxifylline in its pharmaceutical dosage forms. Separation of the drug and the
degradation products، under stress conditions was successfully achieved on a C
18 column
utilizing water: MeOH (60:40 v/v)، pumped at a flow rate of 1 ml min-1 with UV detection
at 272 nm. The retention time of pentoxifylline was about 14 min. The method was
satisfactorily validated with respect to linearity، precision، accuracy and selectivity. The
response was linear in the range of 0.6-3.5 μg/ml with R2 0.994. The method was accurate
(recovery 100.1%) and precise (RSD < 2%). Detection and quantification limit were 0.2
μg/ml and 0.4 μg/ml respectively. The suggested method was successfully applied for the
analysis of pentoxifylline in extended release tablets available in Syrian market.
The purpose of this work is to develop a sensitive, selective and validated
stability–indicating HPLC assay for the analysis of aspartame tablets.
Aspartame and its potential impurities or degradation products are
analyzed on C18 Column using a mo
bile phase containing monobasic
potassium phosphate buffer solution (pH = 3.5) and acetonitrile (85: 15).
